COVID-19 — A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.
Citation(s)
A Single-center, Randomized, Parallel Controlled, Double-blind Clinical Trial Designed to Evaluate the Efficacy and Safety of Hymecromone Tablets in Subjects Diagnosed With COVID-19 Infection.